SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950142-13-001405
Filing Date
2013-05-31
Accepted
2013-05-31 14:41:48
Documents
1
Group Members
AISLING CAPITAL LLCANDREW SCHIFFDENNIS PURCELLPERSEUS-SOROS BIOPHARMACEUTICAL FUND LPPERSEUS-SOROS PARTNERS LLCSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D eh1300826_13d-ambit.htm SC 13D 282896
  Complete submission text file 0000950142-13-001405.txt   284556
Mailing Address 888 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address ARMY & NAVY CLUB BLDG 1627 I ST NW STE 610 WASHINGTON DC 20006 (212) 651-6389
PERSEUS SOROS BIOPHARMACEUTICAL FUND LP (Filed by) CIK: 0001111408 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address 11080 ROSELLE STREET SAN DIEGO CA 92121 8583342100
AMBIT BIOSCIENCES CORP (Subject) CIK: 0001131543 (see all company filings)

IRS No.: 330909648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87467 | Film No.: 13884687
SIC: 2834 Pharmaceutical Preparations